Advantage of Fused-Core® Particle Technology for Oligonucleotide Separations

Bonded Phase: OLIGO C18

Market Segment: Biopharmaceuticals

Particle Size: 2.7 µm

Pore Size: 120 Å

Product Segment: BIOCLASS

Separation Mode: Reversed Phase